KRMN exhibits a critical disconnect between its market price ($70.30) and its deterministic value, with a Piotroski F-Score of 2/9 indicating weak financial health. While the company shows explosive YoY earnings growth (482.9%), the valuation is unsustainable with a P/E ratio of 540.77 and a Graham Number of only $2.91. Heavy insider selling by the CEO and CFO, combined with a sharp recent technical decline, suggests that leadership views the current valuation as an exit opportunity. Despite bullish analyst price targets, the fundamental health and valuation metrics signal a high risk of a significant correction.